Concepedia

LBA20 A randomized, double-blind trial of nivolumab (NIVO) vs placebo (PBO) with neoadjuvant chemotherapy (NACT) followed by adjuvant endocrine therapy (ET) ± NIVO in patients (pts) with high-risk, ER+ HER2− primary breast cancer (BC)

Sherene Loi, Giuseppe Curigliano, Roberto Salgado, Roberto Iván Romero Díaz, Suzette Delaloge, C. Rojas, Marleen Kok, C. Saura Manich, Nadia Harbeck, Elizabeth A. Mittendorf,

Annals of Oncology · 2023 · 99 citations · 0 references

Open access

Concepts

Breast OncologyOncologyMedicineClinical TrialsImmune Checkpoint InhibitorBreast CancerPharmacotherapyCancer TreatmentPharmacologyAdjuvant Endocrine TherapyVs PlaceboNeoadjuvant Chemotherapy